Provider Services

Optimizing Inflammatory Bowel Disease Treatment through Biologic Drug Monitoring

LabCorp's ​DoseASSURE test portfolio provides tests for both drug concentration (TDM) and anti-drug antibody (immunogenicity)

Prediabetes: Know Your Patients’ Risks

There are an estimated 84 million adults 18 years and older in the U.S. who are prediabetic or at risk for developing diabetes.¹  Prediabetes is characterized as higher than normal glucose levels but not high enough to meet criteria for diabetes.²  It is associated with –

Empower Change | Address the Opioid Crisis

Empower Change | Address the Opioid Crisis

LabCorp is the exclusive national laboratory integrated within The Recovery Platform^♦, allowing for seamless access to LabCorp’s medication-assisted treatment (MAT) monitoring services.  The combination of LabCorp’s testing and The Recovery Platform’s software supports compliance with medication-assisted treatment, and helps patients stay on track with their recovery.

Lipids in Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment and Management

Recently, there has been increased discussion around non-fasting cholesterol testing.  This is an appropriate dialogue because testing needs to be convenient and easy to help facilitate patient compliance.  However; it is important that non-fasting cholesterol testing is appropriate for the clinical circumstances in which it is to be used.